Trial · NCT07883421
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | GMT ratio (HD-IIV/SD-IIV) for A/H3N2 strain in the vaccine | Day 14 | |
| Secondary | GMT ratio (HD-IIV/SD-IIV) for A/H3N2 strain in the vaccine | Day 180 and 330 | |
| Secondary | GMT ratio (HD-IIV/SD-IIV) for A/H1N1 strain in the vaccine | Day 14, 180 and 330 | |
| Secondary | GMT ratio (HD-IIV/SD-IIV) for B/Victoria strain in the vaccine | Day 14, 180 and 330 | |
| Secondary | HI GMTs against influenza vaccine strains | Day 14, 180 and 330 | |
| Secondary | Geometric mean ratio (GMR) of HI titres post- versus pre-vaccination against vaccine strains | Day 14 to 330 | |
| Secondary | Seroprotection rates against vaccine strains | Day 14 to 330 | Seroprotection is defined as HI titre ≥1:40 |
| Secondary | Seroconversion rates against vaccines strains | Day 14 to 330 | Seroconversion is defined as a pre-vaccination (Day 0) HI titre \<10 and post-vaccination HI titre ≥40 or at least a 4-fold increase in HI titres from a pre-vaccination HI titre ≥10. |
| Secondary | Micro-neutralization titres against vaccine strains | Day 14, 180 and 330 | |
| Secondary | Frequency of solicited local (injection site) and systemic adverse events | 3 days post-vaccination | |
| Secondary | Severity of solicited local (injection site) and systemic adverse events | 3 days post-vaccination | |
| Secondary | Percentage of subjects with serious adverse events (SAEs) | Day 0 to 330 | |
| Other | Number of subjects reporting influenza like illness (ILI) | Day 14 to 330 | |
| Other | Number of subjects with confirmed influenza infection | Day 14 to 330 | Influenza infection confirmed by lateral flow assay (LFA) and/or polymerase chain reaction (PCR) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07883421/registered